Linked Life Data

8849256

Source:http://linkedlifedata.com/resource/pubmed/id/8849256

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1996-10-24
pubmed:abstractText
We used a mouse model of pneumococcal pneumonia to assess the bactericidal effect of increasing doses of amoxicillin (AMX) against clinical strains with various susceptibilities to penicillin. Twelve strains that exhibited similar virulence in mice were selected. Three were penicillin susceptible (PS) (penicillin and AMX MICs = 0.01 to 0.03 microgram/ml), three were intermediately resistant (PIR) (penicillin and AMX MICs = 0.5 to 1 microgram/ml), and six were penicillin resistant (PR) (penicillin and AMX MICs = 1 to 8 micrograms/ml). Leukopenic Swiss mice were infected intratracheally with 10(7) CFU of each strain. Treatment was initiated 3 h after infection and consisted of a single subcutaneous injection of AMX at doses ranging from 2.5 to 10 mg/kg (PS strains), 5 to 100 (PIR strains), and 25 to 3,000 (PR strains). Bacterial killing kinetics were recorded in the lungs over 9 h. The maximal log CFU reduction (Emax) was observed 3 h postinjection. The relation between Emax and log10(dose/MIC) showed two populations. With seven strains (the three PS, the three PIR, and one of the six PR [MICs, penicillin/AMX = 4/1]) a good correlation was observed between Emax and log10(dose/MIC) (r = 0.772; P < 0.02). A bactericidal effect equal to 3.5 log10 CFU was observed at a log10(dose/MIC) = 2. At this ratio, with the five other PR strains, Emax varied from 0.4 to 1.6 log10 CFU. In brain heart infusion medium containing AMX at 50 times the relevant MIC, these five PR strains were tolerant in vitro. Treatment failure with AMX was found in vivo, with tolerant, highly resistant strains.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-1556558, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-1691615, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-1729176, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-1805140, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-1988515, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-2659573, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-2863313, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-2897398, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-2903859, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-3539006, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-3895353, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-6090396, http://linkedlifedata.com/resource/pubmed/commentcorrection/8849256-7811003
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
941-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
pubmed:affiliation
Institut National de la Santé et de la Recherche Médicale U13, Groupe Hospitalier Bichat-Claude Bernard, Paris, France.
pubmed:publicationType
Journal Article, Comparative Study